Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 1
1950 1
1955 2
1958 1
1960 1
1969 1
1970 1
1977 1
1978 1
1980 2
1981 3
1982 2
1983 4
1984 6
1985 3
1986 8
1987 4
1988 6
1989 5
1990 6
1991 13
1992 15
1993 3
1994 7
1995 6
1996 3
1997 10
1998 9
1999 2
2000 3
2001 3
2002 3
2003 1
2004 4
2005 6
2008 3
2009 2
2010 7
2011 7
2012 3
2013 7
2014 7
2015 9
2016 6
2017 7
2018 4
2019 6
2020 5
2021 7
2022 5
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Behavioural aspects of neuroinflammation.
Willner P, Vanderschuren L, Bergman J. Willner P, et al. Behav Pharmacol. 2019 Dec;30(8):624-625. doi: 10.1097/FBP.0000000000000518. Behav Pharmacol. 2019. PMID: 31703027 No abstract available.
Translational Research in Behavioural Pharmacology.
Vanderschuren L, Bergman J, Jutkiewicz E, Willner P. Vanderschuren L, et al. Among authors: willner p. Behav Pharmacol. 2021 Apr 1;32(2&3):93-94. doi: 10.1097/FBP.0000000000000630. Behav Pharmacol. 2021. PMID: 33720104 No abstract available.
Perspectives for therapy of treatment-resistant depression.
Papp M, Cubala WJ, Swiecicki L, Newman-Tancredi A, Willner P. Papp M, et al. Among authors: willner p. Br J Pharmacol. 2022 Sep;179(17):4181-4200. doi: 10.1111/bph.15596. Epub 2021 Jul 29. Br J Pharmacol. 2022. PMID: 34128229 Free article. Review.
The behavioural pharmacology of stress-related disorders.
Willner P, Bergman J, Vanderschuren L. Willner P, et al. Behav Pharmacol. 2019 Apr;30(2 and 3-Spec Issue):101-103. doi: 10.1097/FBP.0000000000000481. Behav Pharmacol. 2019. PMID: 30882423 No abstract available.
The behavioural pharmacology of opioids.
Willner P, Bergman J, Vanderschuren L. Willner P, et al. Behav Pharmacol. 2020 Apr;31(2&3):109-111. doi: 10.1097/FBP.0000000000000560. Behav Pharmacol. 2020. PMID: 32168023 No abstract available.
Behavioural pharmacology of impulse control.
Willner P, Bergman J, Sanger D. Willner P, et al. Behav Pharmacol. 2009 Sep;20(5-6):558-60. doi: 10.1097/01.fbp.0000359407.60839.2d. Behav Pharmacol. 2009. PMID: 19741302 No abstract available.
Depression: from psychopathology to pathophysiology.
Belzung C, Willner P, Philippot P. Belzung C, et al. Among authors: willner p. Curr Opin Neurobiol. 2015 Feb;30:24-30. doi: 10.1016/j.conb.2014.08.013. Epub 2014 Sep 15. Curr Opin Neurobiol. 2015. PMID: 25218233 Review.
Editorial: The Behavioural Pharmacology of Cannabinoids.
Vanderschuren L, Jutkiewicz E, Willner P, Ellenbroek B. Vanderschuren L, et al. Among authors: willner p. Behav Pharmacol. 2022 Apr 1;33(2&3):61-62. doi: 10.1097/FBP.0000000000000673. Behav Pharmacol. 2022. PMID: 35288508 No abstract available.
219 results